Current Issue

Sponsored
Keywords

Cancer - Related Content

Feature Articles: Cancer Diagnostics, Pushing the Boundaries
Sidebars: Highlights from AACR
Corporate Profiles: Softening the Blow from FOLFOX Treatment
PledPharma’s Modified Form of Mangafodipir Shown to Reduce Side Effects of Chemotherapy
Feature Articles: Querying the Cancer Transcriptome
BioPerspectives: New Biomarkers Could Offer Vital Clues for Cancer Research
European funding for cancer research has led to some interesting results in recent years.

Cancer’s Bitter Medicine
May 22, 2013
CML experts raise industry hackles by decrying high-and-rising cost of treatments.
Moving Genomics Closer to the Clinic
May 16, 2013
Foundation Medicine and Memorial Sloan-Kettering Cancer Center are working to translate genomic information into personalized cancer treatment.
Literature Review: A Step Closer to Personalized Medicine
May 15, 2013
Researchers use patient-specific cell lines derived in mice to personalize chemotherapy.
The Tumor Microenvironment as a Drug Target, Part II
May 10, 2013
In the search for new targets, cancer researchers are taking a closer look at the cellular support networks that allow tumors to survive.
The Tumor Microenvironment as a Drug Target: Chasing Slippery Targets
May 2, 2013
This first part of a two-part series discusses how researchers are looking at ways to attack tumors by targeting the cellular frameworks that keep them alive.

Tissue-Engineered Tumor Models
Marylou Ingram, M.D., Senior Research Scientist, and Director, In Vitro Systems/Tissue Engineering, Huntington Medical Research Institutes, Pasadena, CA
Stapled Peptides Making Progress
Gregory L. Verdine, Ph.D., Harvard College Professor and Erving Professor of Chemistry, Department of Cellular and Molecular Biology, Harvard University, and Founder and Co-Chairman, Scientific Advisory Board, Aileron Therapeutics
Protecting the Body’s Tissues After DNA Damage
Michael B. Kastan, M.D., Ph.D., Director, Comprehensive Cancer Center, St. Jude Children’s Research Hospital, Memphis, TN
PROTEIN IMPORTANT IN DIABETES FOUND TO PLAY ROLE IN OTHER DISEASES
Struan Grant, Ph.D., is Associate Director of the Center for Applied Genomics at the Children’s Hospital of Philadelphia and Assistant Professor of Pediatrics, Department of Pediatrics, University of Pennsylvania School of Medicine
NOVEL RETRIEVAL METHOD FOR STUDYING CANCER PROTEINS
Interview with W. Andy Tao, Ph.D., Assistant Professor, Analytical Chemistry and Chemical Biology, Purdue University

	Roche Sequencing Assays GS GType TET2/CBL/KRAS and the GS GType RUNX1 primer sets are designed for comprehensive genetic variation detection in four key human genes using the 454 GS Junior and GS FLX Systems. The sequence-based assays offer a solution for cancer researche
	Randox Laboratories Tumor Marker Control The Acusera multianalyte liquid tumor marker control covers a total of 15 commonly tested and esoteric cancer antigens and tumor markers. Assayed target values can help laboratories monitor both accuracy and precision. The liquid stable nature redu
	Mirus Bio Transfection Reagent TransIT®-BrCa transfection reagent is a dedicated breast cancer cell-line specific reagent that can help researchers achieve high expression levels in breast cancer cell types including MCF-7, MDA-MB-231, MDA-MB-453, MDA-MB-468, and T47D. It c
	Cellectis bioresearch Knockout Cell Lines for Cancer Research The cells in CanCELL™ cell lines represent comprehensive knockouts of major disease-relevant oncogenes and tumor suppressor genes. CanCELL cell lines are generated using TALEN™ technology and offer opportunities to study signaling pathways and gene
	Horizon Discovery DNA Reference Standard The Quantitative Multiplex DNA reference standard is intended for researchers assessing multiple biomarkers in a single assay using platforms such as next-generation sequencing. It can enable researchers to quantify a range of detection thresholds